share_log

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K:外国发行人报告
美股SEC公告 ·  04/29 06:22
Moomoo AI 已提取核心信息
Alterity Therapeutics Limited, a development stage enterprise, has announced the application for quotation of additional securities on the ASX. The announcement, dated April 29, 2024, specifies that 7,097,419 ordinary fully paid shares will be quoted following the exercise of options or conversion of other convertible securities. These shares were issued on April 22, 2024, at an issue price of AUD 0.007 each. The new securities will rank equally with the existing issued securities in that class. Following this quotation, Alterity Therapeutics' issued capital will include over 5 billion ordinary shares and a variety of options with different expiration dates and exercise prices.
Alterity Therapeutics Limited, a development stage enterprise, has announced the application for quotation of additional securities on the ASX. The announcement, dated April 29, 2024, specifies that 7,097,419 ordinary fully paid shares will be quoted following the exercise of options or conversion of other convertible securities. These shares were issued on April 22, 2024, at an issue price of AUD 0.007 each. The new securities will rank equally with the existing issued securities in that class. Following this quotation, Alterity Therapeutics' issued capital will include over 5 billion ordinary shares and a variety of options with different expiration dates and exercise prices.
处于发展阶段的企业Alterity Therapeutics Limited已宣布在澳大利亚证券交易所申请额外证券的报价。该公告于2024年4月29日发布,其中规定,在行使期权或转换其他可转换证券后,将对7,097,419股全额支付的普通股进行报价。这些股票于2024年4月22日发行,每股发行价为0.007澳元。新证券的排名将与该类别中现有已发行证券的排名相同。在本次报价之后,Alterity Therapeutics的已发行资本将包括超过50亿股普通股和各种具有不同到期日和行使价的期权。
处于发展阶段的企业Alterity Therapeutics Limited已宣布在澳大利亚证券交易所申请额外证券的报价。该公告于2024年4月29日发布,其中规定,在行使期权或转换其他可转换证券后,将对7,097,419股全额支付的普通股进行报价。这些股票于2024年4月22日发行,每股发行价为0.007澳元。新证券的排名将与该类别中现有已发行证券的排名相同。在本次报价之后,Alterity Therapeutics的已发行资本将包括超过50亿股普通股和各种具有不同到期日和行使价的期权。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息